The translational landscape of mTOR signalling steers cancer initiation and metastasisAndrew C. Hsieh, Davide Ruggero, Yi Liu et al.|Nature|2012Cited by 1.4k
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorMatthew R. Janes, Melissa A Chavez, Collin Vu et al.|Nature Medicine|2010Cited by 338
The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitorsAlex Berndt, Roger Williams, Simon Miller et al.|Nature Chemical Biology|2010Cited by 292